Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02998476
Brief Title: A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)

First Submitted : December 13, 2016
First Submitted that Met QC Criteria : December 15, 2016
First Posted : December 20, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : September 11, 2019
Last Update Posted : September 13, 2019